Follow
Łukasz Kuźbicki
Łukasz Kuźbicki
Verified email at umk.pl
Title
Cited by
Cited by
Year
Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours
BW Chwirot, L Kuzbicki
Melanoma Research 17 (3), 139-145, 2007
642007
Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression
L Kuzbicki, A Sarnecka, BW Chwirot
Melanoma Research 16 (1), 29-36, 2006
612006
JARID1B expression in human melanoma and benign melanocytic skin lesions
L Kuzbicki, D Lange, A Straczynska-Niemiec, BW Chwirot
Melanoma Research 23 (1), 8-12, 2013
262013
The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions
L Kuzbicki, D Lange, A Straczynska-Niemiec, BW Chwirot
Melanoma Research 22 (1), 70-76, 2012
222012
Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma
L Kuzbicki, D Lange, A Stanek-Widera, BW Chwirot
Melanoma Research 26 (5), 448-456, 2016
212016
Different expression of cyclooxygenase-2 (COX-2) in selected nonmelanocytic human cutaneous lesions
L Kuzbicki, D Lange, A Stanek-Widera, BW Chwirot
Folia Histochemica et Cytobiologica 49 (3), 381-388, 2011
172011
Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions
L Kuzbicki, E Aladowicz, BW Chwirot
Melanoma Research 16 (5), 435-444, 2006
172006
Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies
L Kuzbicki, D Lange, BW Chwirot
Melanoma Research 19 (5), 294-300, 2009
162009
Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions
L Kuzbicki, B Gajo, BW Chwirot
Melanoma Research 16 (3), 235-243, 2006
92006
Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients
J Urban, L Kuzbicki, G Szatkowski, A Stanek-Widera, D Lange, ...
BMC Cancer 14, 732, 2014
82014
Prognostic significance of RBP2-H1 variant of JARID1B in melanoma
Ł Kuźbicki, D Lange, A Stanek-Widera, BW Chwirot
BMC Cancer 17, 854, 2017
72017
Immunohistochemical detectability of cyclooxygenase-2 expression in cells of human melanocytic skin lesions: A methodological review
Ł Kuźbicki, AA Brożyna
Journal of Cutaneous Pathology 47 (4), 363-380, 2020
52020
Cyclin-dependent Kinase 2 (CDK-2) expression in nonmelanocytic human cutaneous lesions
L Kuzbicki, D Lange, A Stanek-Widera, BW Chwirot
Applied Immunohistochemistry & Molecular Morphology 18 (4), 357-364, 2010
52010
Different detectability of cyclooxygenase-2 (COX-2) protein in standard paraffin sections and tissue microarrays of human melanomas and naevi–Comparative study
L Kuzbicki, J Urban, BW Chwirot
Pathology-Research and Practice 210 (9), 591-595, 2014
32014
Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma?
Ł Kuźbicki, D Lange, A Stanek-Widera, A Glińska, BW Chwirot
Oncotarget 9 (25), 17656-17663, 2018
22018
Altered Splicing of JARID1B in Development of Human Cutaneous Melanoma?
L Kuzbicki, D Lange, A Straczynska-Niemiec, BW Chwirot
Applied Immunohistochemistry & Molecular Morphology 24 (3), 188-192, 2016
22016
Expression of Cyclooxygenase-2 in Human Epithelial Skin Lesions: A Systematic Review of Immunohistochemical Studies.
Ł Kuźbicki, AA Brożyna
Applied Immunohistochemistry & Molecular Morphology 29 (3), 163-174, 2021
12021
Cyclooxygenase‐2 overexpression as indicator of favorable clinicopathological phenotype and better survival of colorectal cancer patients: Fact or artifact?
BW Chwirot, J Urban, L Kuzbicki
Basic and Applied Pathology 4 (1), 33-33, 2011
12011
Near-infrared, wavelength, and illumination scanning holographic tomography
P Ossowski, A Kuś, W Krauze, S Tamborski, M Ziemczonok, Ł Kuźbicki, ...
Biomedical Optics Express 13 (11), 5971-5988, 2022
2022
The markers auxiliary in differential diagnosis of early melanomas and benign nevi sharing some similar features potentially leading to misdiagnosis-a review of …
Ł Kuźbicki, AA Brożyna
Cancer Investigation 40 (10), 852-867, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20